FEBRUARY 2015
Rightly stated by our health minister that any research in the field of medicine, whether it is in the area of medical equipments and devices, drugs or even in best practices and systems change, needs to have people at its centre. Innovation can be complete and meaningful only when it benefits the last person in the delivery chain, and those who are most vulnerable and needy. But there should be some scope for pharmaceutical industries too. Present editorial focused on same.
Present issue contains reviews on role of laser photocoagulation in diabetic retinopathy, plagiarism, parkinsonism, targeted drug delivery systems for lung cancer, application of analytical method development on new fixed dose combination of irbesartan and atorvastatin and case study on hemolytic uremic syndrome.
Researches include estimation of linezolid and cefixime, difference spectroscopic method for the estimation of acebutolol hydrochloride and molecular docking studies of n-(2-benzoylphenyl)-l-tyrosine derivatives.
.png)
